Management of Familial Adenomatous Polyposis (FAP)
Adults with confirmed FAP require prophylactic colorectal surgery once florid polyposis develops, combined with lifelong upper gastrointestinal surveillance starting at age 25 years, as this approach has been proven to reduce colorectal cancer mortality from 50-70% to 3-10%. 1, 2
Colorectal Surveillance and Surgical Timing
Pre-Surgical Surveillance
For adults already diagnosed with FAP who have not yet undergone surgery, colonoscopy should be performed every 1-3 years depending on polyp burden 2. This individualized interval is based on the colonic phenotype and polyp progression rate.
Indications for Surgery
Absolute indications requiring immediate surgery: 2
- Documented or suspected colorectal cancer
- Significant symptoms attributable to polyposis (bleeding, obstruction, severe diarrhea)
Relative indications for elective surgery: 2
- Polyps >10 mm in diameter
- High-grade dysplasia within polyps
- Significant increase in polyp burden between examinations
The evidence strongly supports that prophylactic colectomy before malignant transformation is the cornerstone of FAP management, as surveillance alone cannot prevent cancer indefinitely 1.
Surgical Options
Total colectomy with ileorectal anastomosis (IRA) is preferred when feasible, as it provides superior quality of life compared to restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA), with acceptable oncological risk if patients adhere to lifelong rectal surveillance 3, 4.
Key surgical considerations:
- Counsel patients about desmoid disease risk post-operatively (occurs in 10-15% of FAP patients) 1, 2
- Assess genotype and family history of desmoids before surgery, as certain APC mutations predict higher desmoid risk 2
- IRA requires rigorous lifelong endoscopic surveillance of the rectal remnant 3
- IPAA may be necessary if rectal polyp burden is too severe or if cancer risk in rectum is deemed too high
Upper Gastrointestinal Surveillance
Begin upper GI endoscopy at age 25 years 2. This is critical because duodenal cancer is the second leading cause of cancer death in FAP patients after colorectal cancer, and gastric cancer prevalence is increasing 5.
The surveillance interval for upper GI tract depends on the Spigelman staging of duodenal polyposis, though specific intervals should be determined by the endoscopist based on polyp burden and dysplasia grade 6.
Management of Extracolonic Manifestations
Desmoid Disease
Desmoids represent the highest extracolonic mortality risk and occur in at least 10-15% of FAP patients 1, 5. These connective tissue tumors, though histologically benign, can cause life-threatening complications through mass effect on vital structures.
Medical management: Sulindac combined with high-dose selective estrogen receptor modulators may be effective for intra-abdominal and abdominal wall desmoids 2.
Surgical approach: Elective surgery for intra-abdominal desmoids should be restricted to treating secondary effects (bowel obstruction, vascular compromise) and performed only at expert centers 2. Primary resection often leads to recurrence and should be avoided.
Other Surveillance Needs
- Thyroid: Monitor for thyroid nodules, particularly the cribriform morular variant of papillary thyroid cancer 5
- Ophthalmologic: Patients with congenital hypertrophy of retinal pigment epithelium (CHRPE) should receive specialist ophthalmic review 2
Critical Pitfalls to Avoid
Delaying surgery too long: The near 100% lifetime risk of colorectal cancer means that "watchful waiting" beyond appropriate surgical timing is dangerous 1, 4
Inadequate post-colectomy surveillance: Even after total colectomy with IRA, the rectal remnant requires lifelong surveillance as cancer can still develop 3, 4
Neglecting upper GI surveillance: With improved colorectal management, duodenal cancer has become a leading cause of death in FAP 5
Aggressive surgical approach to desmoids: Surgery for intra-abdominal desmoids often worsens outcomes and should be reserved for complications only 2
Multidisciplinary Management
All FAP patients should be managed at specialized centers with multidisciplinary teams 7, 3. The complexity of surgical decision-making, desmoid management, upper GI surveillance, and genetic counseling requires expertise that is best concentrated in high-volume centers.
The evidence consistently demonstrates that centralized registration and coordinated surveillance programs have reduced CRC-associated mortality in FAP from historical rates of 50-70% in symptomatic cases to 3-10% in surveilled patients 1.